Pathologic and Immunophenotypic Characterization of Syncytial Giant Cell Variant of Pediatric Hepatocellular Carcinoma. A Distinct Subtype

References

• Kelly D, Sharif K, Brown RM, Morland B. Hepatocellular carcinoma in children. Clin Liver Dis. 2015;19(2):433–47. doi:10.1016/j.cld.2015.01.010.
   PubMed Web of Science ®Google Scholar
• Palaniappan K, Borkar VV, Safwan M, Vij M, Govil S, Shanmugam N, Rela M. Pediatric hepatocellular carcinoma in a developing country: Is the etiology changing? Pediatr Transplant. 2016;20(7):898–903. doi:10.1111/petr.12754.
   PubMed Web of Science ®Google Scholar
• Schmid I, von Schweinitz D. Pediatric hepatocellular carcinoma: challenges and solutions. J Hepatocell Carcinoma. 2017;4:15–21. doi:10.2147/JHC.S94008.
   PubMed Web of Science ®Google Scholar
• Jeyaraj R, Kelly D. Rare inherited cholestatic disorders and molecular links to hepatocarcinogenesis. Cells. 2022;11(16):2570. doi:10.3390/cells11162570.
   PubMed Web of Science ®Google Scholar
• Menon J, Shanmugam N, Vij M, Rammohan A, Rela M. Liver transplantation in tight junction protein-2 deficiency associated liver disease. Liver Transpl. 2022;28(11):1796–9. doi:10.1002/lt.26515.
   PubMed Web of Science ®Google Scholar
• Valamparampil JJ, Shanmugam N, Vij M, Reddy MS, Rela M. Hepatocellular carcinoma in paediatric patients with alagille syndrome: case series and review of literature. J Gastrointest Cancer. 2020;51(3):1047–52. doi:10.1007/s12029-020-00391-2.
   PubMed Web of Science ®Google Scholar
• Menon J, Shanmugam N, Valamparampil JJ, Hakeem A, Vij M, Jalan A, Reddy MS, Rela M. Liver transplantation: a safe and definitive alternative to lifelong nitisinone for tyrosinemia type 1. Indian J Pediatr. 2022;89(5):438–44. doi:10.1007/s12098-021-03826-1.
   PubMed Web of Science ®Google Scholar
• Leduc CA, Crouch EE, Wilson A, Lefkowitch J, Wamelink MM, Jakobs C, Salomons GS, Sun X, Shen Y, Chung WK. Novel association of early onset hepatocellularcarcinoma with transaldolase deficiency. JIMD Rep. 2014;12:121–7. doi:10.1007/8904_2013_254.
   PubMedGoogle Scholar
• Baumann U, Adam R, Duvoux C, Mikolajczyk R, Karam V, D’Antiga L, Chardot C, Coker A, Colledan M, Ericzon BG, European Liver and Intestine Transplant Association, et al. Survival of children after liver transplantation for hepatocellular carcinoma. Liver Transpl. 2018;24(2):246–55. doi:10.1002/lt.24994.
   PubMed Web of Science ®Google Scholar
• D’Souza AM, Towbin AJ, Gupta A, Alonso M, Nathan JD, Bondoc A, Tiao G, Geller JI. Clinical heterogeneity of pediatric hepatocellular carcinoma. Pediatr Blood Cancer. 2020;67(6):e28307. doi:10.1002/pbc.28307.
   PubMed Web of Science ®Google Scholar
• Haines K, Sarabia SF, Alvarez KR, Tomlinson G, Vasudevan SA, Heczey AA, Roy A, Finegold MJ, Parsons DW, Plon SE, et al. Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diversesignaling pathway activation. Pediatr Blood Cancer. 2019;66(7):e27745. doi:10.1002/pbc.27745.
   PubMed Web of Science ®Google Scholar
• Cowell E, Patel K, Heczey A, Finegold M, Venkatramani R, Wu H, López-Terrada D, Miloh T. Predisposing conditions to pediatric hepatocellular carcinoma and association with outcomes: single-center experience. J Pediatr Gastroenterol Nutr. 2019;68(5):695–9. doi:10.1097/MPG.0000000000002285.
   PubMed Web of Science ®Google Scholar
• Vij M, Calderaro J. Pathologic and molecular features of hepatocellular carcinoma: an update. World J Hepatol. 2021;13(4):393–410. doi:10.4254/wjh.v13.i4.393.
   PubMed Web of Science ®Google Scholar
• Cho SJ, Makhlouf HR, Ranganathan S. Fibrolamellar variant of hepatocellular carcinoma. In: WHO Classification of Tumours Editorial Board, editor. Digestive system tumours. WHO classification of tumours series. 5th ed. Lyon: International Agency for Research on Cancer, 2019.
   Google Scholar
• Cho SJ, Guettier C, Hiyama E, Hala R, Makhlouf HR, Ranganathan S, Rangaswami A. Pediatric hepatocellular carcinoma. In: WHO Classification of Tumours Editorial Board, editor. Digestive system tumours. WHO classification of tumours series. 5th ed. Lyon: International Agency for Research on Cancer, 2019.
   Google Scholar
• Allan BJ, Wang B, Davis JS, Parikh PP, Perez EA, Neville HL, Sola JE. A review of 218 pediatric cases of hepatocellular carcinoma. J Pediatr Surg. 2014;49(1):166–71; discussion 171. Epub 2013 Oct 5. PMID: 24439603. doi:10.1016/j.jpedsurg.2013.09.050.
   PubMed Web of Science ®Google Scholar
• Zen Y, Vara R, Portmann B, Hadzic N. Childhood hepatocellular carcinoma: a clinicopathological study of 12 cases with special reference to EpCAM. Histopathology. 2014;64(5):671–82. Epub 2013 Dec 2.PMID: 24138022. doi:10.1111/his.12312.
   PubMed Web of Science ®Google Scholar
• Vij M, Shanmugam NP, Reddy MS, Govil S, Rela M. Hepatocarcinogenesis in multidrug-resistant P-glycoprotein 3 deficiency. Pediatr Transplant. 2017;21(3):e12889. Epub 2017 Jan 27. PMID: 28127842. doi:10.1111/petr.12889.
   Web of Science ®Google Scholar
• Atra A, Al-Asiri R, Wali S, Al-Husseini H, Al-Bassas A, Zimmermann A. Hepatocellular carcinoma, syncytial giant cell: a novel variant in children: acase report. Ann Diagn Pathol. 2007;11(1):61–3. PMID: 17240310. doi:10.1016/j.anndiagpath.2005.12.005.
   PubMed Web of Science ®Google Scholar
• Pinon M, Gambella A, Giugliano L, Chiadò C, Kalantari S, Bracciamà V, Deaglio S, Tinti D, Peruzzi L, Cotti R, et al. New case of syncytial giant-cell variant of hepatocellularcarcinoma in a pediatric patient with HNF1B deficiency: does it fit withthe syndrome? BMJ Open Gastroenterol. 2022;9(1):e001013. PMID: 36572455 doi:10.1136/bmjgast-2022-001013.
   PubMed Web of Science ®Google Scholar
• Sumazin P, Peters TL, Sarabia SF, Kim HR, Urbicain M, Hollingsworth EF, Alvarez KR, Perez CR, Pozza A, Najaf Panah MJ, et al. Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults. J Hepatol. 2022;77(4):1026–37. doi:10.1016/j.jhep.2022.04.035.Epub.2022 May 14. PMID: 35577029; PMCID: PMC9524481.
   PubMed Web of Science ®Google Scholar
• Vij M, Rela M. Biliary atresia: pathology, etiology and pathogenesis. Future Sci Oa. 2020;6(5):FSO466. PMID: 32518681; PMCID: PMC7273417. doi:10.2144/fsoa-2019-0153.
   PubMed Web of Science ®Google Scholar
• Hadžić N, Quaglia A, Portmann B, Paramalingam S, Heaton ND, Rela M, Mieli-Vergani G, Davenport M. Hepatocellular carcinoma in biliary atresia: King’s College Hospital experience. J Pediatr. 2011;159(4):617–22.e1. Epub 2011 Apr 13. PMID: 21489554. doi:10.1016/j.jpeds.2011.03.004.
   PubMed Web of Science ®Google Scholar
• Hirzel AC, Madrazo B, Rojas CP. Two rare cases of hepatocellular carcinoma after kasai procedure for biliary atresia: a recommendation for close follow-up. Case Rep Pathol. 2015;2015:982679. Epub 2015 Aug 3.PMID: 26339518; PMCID: PMC4539070. doi:10.1155/2015/982679.
   PubMedGoogle Scholar
• Xue J, Han J, Zhao X, Zhen L, Mei S, Hu Z, Li X. Prenatal diagnosis of fetus with transaldolase deficiency identifies compound heterozygous variants: a case report. Front Genet. 2021;12:752272. PMID:35186000; PMCID: PMC8855097. doi:10.3389/fgene.2021.752272.
   PubMed Web of Science ®Google Scholar
• Grammatikopoulos T, Hadzic N, Foskett P, Strautnieks S, Samyn M, Vara R, Dhawan A, Hertecant J, Al Jasmi F, Rahman O, University of Washington Center forMendelian Genomics, et al. Liver disease and riskof hepatocellular carcinoma in children with mutations in TALDO1. Hepatol Commun. 2022;6(3):473–9. Epub 2021 Oct 22. PMID:34677006; PMCID: PMC8870026. doi:10.1002/hep4.1824.
   PubMed Web of Science ®Google Scholar
• Balasubramaniam S, Wamelink MM, Ngu LH, Talib A, Salomons GS, Jakobs C, Keng WT. Novel heterozygous mutations in TALDO1 gene causing transaldolase deficiency and early infantile liver failure. J Pediatr Gastroenterol Nutr. 2011;52(1):113–6. PMID: 21119539. doi:10.1097/MPG.0b013e3181f50388.
   PubMed Web of Science ®Google Scholar
• Hanczko R, Fernandez DR, Doherty E, Qian Y, Vas G, Niland B, Telarico T, Garba A, Banerjee S, Middleton FA, et al. Prevention of hepatocarcinogenesis and increased susceptibility toacetaminophen-induced liver failure in transaldolase-deficient mice byN-acetylcysteine. J Clin Invest. 2009;119(6):1546–57. doi:10.1172/JCI35722.Epub.2009 May 11. PMID: 19436114; PMCID: PMC2689120.
   PubMed Web of Science ®Google Scholar
• Tsukimoto M, Sugimoto K, Shigefuku R, Sugimoto R, Yuasa H, Uchida K, Yamamoto N. Recurrent hepatocellular carcinoma with osteoclast-like giant cells: a casereport. J Med Case Rep. 2022;16(1):142. PMID: 35361276; PMCID: PMC8974057 doi:10.1186/s13256-022-03355-1.
   PubMedGoogle Scholar
• Li Y, Farmer RW, Yang Y, Martin RC. Epithelial cell adhesion molecule in human hepatocellular carcinoma cell lines: a target of chemoresistence. BMC Cancer. 2016;16:228. PMID: 26984381; PMCID: PMC4794840. doi:10.1186/s12885-016-2252-y.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Dungubat E, Kusano H, Ganbat D, Tomita Y, Odgerel S, Fukusato T. Application of immunohistochemistry in the pathological diagnosis of liver tumors. IJMS. 2021;22(11):5780. PMID:34071338; PMCID: PMC8198626. doi:10.3390/ijms22115780.
   Google Scholar
• Yamashita T, Forgues M, Wang W, Kim JW, Ye Q, Jia H, Budhu A, Zanetti KA, Chen Y, Qin LX, et al. EpCAM and alpha-fetoprotein expression definesnovel prognostic subtypes of hepatocellular carcinoma. Cancer Res. 2008;68(5):1451–61. PMID: 18316609. doi:10.1158/0008-5472.CAN-07-6013.
   PubMed Web of Science ®Google Scholar
• Si M, Lang J. The roles of metallothioneins in carcinogenesis. J Hematol Oncol. 2018;11(1):107. PMID: 30139373; PMCID: PMC6108115. doi:10.1186/s13045-018-0645-x.
   PubMed Web of Science ®Google Scholar
• Fu CL, Pan B, Pan JH, Gan MF. Metallothionein 1M suppresses tumorigenesis in hepatocellular carcinoma. Oncotarget. 2017;8(20):33037–46. PMID: 28380433; PMCID: PMC5464848. doi:10.18632/oncotarget.16521.
   PubMedGoogle Scholar